help button home button Am J Pathol Epitomics, Inc.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Originally published online as doi:10.2353/ajpath.2009.090698 on September 3, 2009

Published online before print September 3, 2009
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
ajpath.2009.090698v1
175/4/1371    most recent
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by Kizu, A.
Right arrow Articles by Kalluri, R.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kizu, A.
Right arrow Articles by Kalluri, R.
(American Journal of Pathology. 2009;175:1371-1373.)
© 2009 American Society for Investigative Pathology
DOI: 10.2353/ajpath.2009.090698

Commentary

Endothelial–Mesenchymal Transition as a Novel Mechanism for Generating Myofibroblasts during Diabetic Nephropathy

Akane Kizu*, Damian Medici* and Raghu Kalluri*{dagger}{ddagger}

From the Division of Matrix Biology,* Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston; the Department of Biological Chemistry and Molecular Pharmacology,{dagger} Harvard Medical School, Boston; and the Harvard-Massachusetts Institute of Technology Division of Health Sciences and Technology,{ddagger} Boston, Massachusetts

Abstract

This Commentary provides perspective on epithelial-mesenchymal transition in diabetic nephropathy.






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2009 by the American Society for Investigative Pathology.